Nevskin



Compound IDCDAMM01421
Common nameNevskin
IUPAC name7-[(2,6-dihydroxy-2,5,5,8a-tetramethyl-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl)methoxy]chromen-2-one
Molecular formulaC24H32O5

Experimental data

Retention time8.31
Adduct[M+K]+
Actual mz439.188
Theoretical mz439.188
Error1.5
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.7524

Identifiers and class information

Inchi keyWNANPKYNOALKIV-UHFFFAOYNA-N
SmilesO=C1OC=2C=C(OCC3C(O)(C)CCC4C(C)(C)C(O)CCC34C)C=CC2C=C1
SuperclassPhenylpropanoids and polyketides
ClassCoumarins and derivatives

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)5
Number of reactive functional groups (#rtvFG)1
Predicted central nervous system activity (CNS)-1
Molecular weight (mol_MW)400.514
Computed dipole moment(dipole)5.781
Total solvent accessible surface area (SASA)665.26
Hydrophobic component of SASA (FOSA)340.12
Hydrophilic component of SASA (FISA)131.126
Pie component of the SASA (PISA)194.014
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1249.15
Number of hydrogen bond donors (donorHB)2
Number of hydrogen bond acceptors (accptHB)5.7
Free energy of solvation of dipole (dip^2/V)0.0267498
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0121171
Globularity descriptor (glob)0.843174
Predicted polarizability in cubic angstroms (QPpolrz)42.479
Predicted hexadecane/gas partition coefficient (QPlogPC16)12.56
Predicted octanol/gas partition coefficient (QPlogPoct)20.403
Predicted water/gas partition coefficient (QPlogPw)10.973
Predicted octanol/water partition coefficient (QPlogPo/w)3.926
Predicted aqueous solubility (QPlogS)-5.433
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.567
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.995
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)565.497
Predicted brain/blood partition coefficient (QPlogBB)-0.967
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)267.151
Predicted skin permeability, log Kp (QPlogKp)-2.773
PM3 calculated ionization potential (IP(ev))9.209
PM3 calculated electron affinity (EA(eV))0.873
Number of likely metabolic reactions (#metab)3
Prediction of binding to human serum albumin (QPlogKhsa)0.663
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)100
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)84.124
Number of nitrogen and oxygen atoms (#NandO)5
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
O43570CA12Carbonic anhydrase XIIT16987SwissTargetPrediction and SEA
Q16790CA9Carbonic anhydrase IXT64567SwissTargetPrediction and SEA
P43166CA7Carbonic anhydrase VIIT37541SwissTargetPrediction and SEA
P23280CA6Carbonic anhydrase VIT06569SEA
Q9ULX7CA14Carbonic anhydrase XIVT31992SEA
P22748CA4Carbonic anhydrase IVT53378SEA
P27338MAOBMonoamine oxidase BT83011SEA
P18031PTPN1Protein-tyrosine phosphatase 1BT16347SEA
P17706PTPN2T-cell protein-tyrosine phosphataseT49156SEA
P06276BCHEButyrylcholinesteraseT99799SEA
P01584IL1BInterleukin-1 betaT42000SEA
Q15119PDK2Pyruvate dehydrogenase kinase isoform 2T17967SEA
Q9NZ08ERAP1Endoplasmic reticulum aminopeptidase 1T72849SEA
O15427SLC16A3Monocarboxylate transporter 4T31788SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T16987DI0046Bacterial infection[ICD-11: 1A00-1C4Z]O43570CA12
T16987DI0372Seborrhoeic dermatitis[ICD-11: EA81]O43570CA12
T64567DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q16790CA9
T06569DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P23280CA6
T06569DI0372Seborrhoeic dermatitis[ICD-11: EA81]P23280CA6
T31992DI0046Bacterial infection[ICD-11: 1A00-1C4Z]Q9ULX7CA14
T31992DI0204Inborn metabolism deficiency[ICD-11: 5C50-5C59]Q9ULX7CA14
T53378DI0046Bacterial infection[ICD-11: 1A00-1C4Z]P22748CA4
T53378DI0166Glaucoma[ICD-11: 9C61]P22748CA4
T53378DI0372Seborrhoeic dermatitis[ICD-11: EA81]P22748CA4
T83011DI0115Dementia[ICD-11: 6D80-6D8Z]P27338MAOB
T83011DI0117Depression[ICD-11: 6A70-6A7Z]P27338MAOB
T83011DI0190Hypertension[ICD-11: BA00-BA04]P27338MAOB
T83011DI0243Malaria[ICD-11: 1F40-1F45]P27338MAOB
T83011DI0264Migraine[ICD-11: 8A80]P27338MAOB
T83011DI0331Parkinsonism[ICD-11: 8A00]P27338MAOB
T16347DI0009Acute diabete complication[ICD-11: 5A2Y]P18031PTPN1
T16347DI0062Breast cancer[ICD-11: 2C60-2C6Y]P18031PTPN1
T16347DI0308Obesity[ICD-11: 5B80-5B81]P18031PTPN1
T16347DI0417Type 2 diabetes mellitus[ICD-11: 5A11]P18031PTPN1
T49156DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P17706PTPN2
T99799DI0324Pain[ICD-11: MG30-MG3Z]P06276BCHE
T99799DI0411Tonus and reflex abnormality[ICD-11: MB47]P06276BCHE
T42000DI0267Mineral excesses[ICD-11: 5B91]P01584IL1B
T42000DI0269Monogenic autoinflammatory syndrome[ICD-11: 4A60]P01584IL1B
T42000DI0320Osteoarthritis[ICD-11: FA00-FA05]P01584IL1B
T42000DI0366Rheumatoid arthritis[ICD-11: FA20]P01584IL1B
T17967DI0009Acute diabete complication[ICD-11: 5A2Y]Q15119PDK2

Copyright © 2025